An observational study in Infective Endocarditis, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2024-01-08.
Sponsored by Central Hospital, Nancy, France · Observational
ELDERL-IE is a multicenter national prospective observational study.
The main objective is to describe geriatric characteristics (comorbidities, cognitive status, autonomy, nutritional status, balance and walking) in patients aged 75 years or older with infective endocarditis (IE).
The secondary objectives are to assess the impact of geriatric features on the medico - surgical care and on morbidity and mortality at 3 months after the end of the hospitalization, and to describe the initial clinical presentation and diagnostic modalities in the IE elderly.
Population monitoring:
Clinical, therapeutic, biological, microbiological, echocardiographic and geriatric data are collected. (M-2/3 before inclusion; D-15 before inclusion; D0; M3; vital status at 1 year)
173 studies on the registry are indexed under Endocarditis; 57 are open to participants now.
This study's enrollment of 120 is below the median of 225 across 82 observational studies indexed under Endocarditis.
Browse Endocarditis studies →Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients older than 75 years are eligible if they are considered and treated as a case of IE by physicians ensuring their medical care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria :
Change from baseline geriatric characteristics at 3 months
OMS score
Time frame: 3 months after inclusion
Three months mortality
Mortality rate at 3 months
Time frame: 3 months after inclusion
One year mortality
Mortality rate at 1 year
Time frame: 1 year after inclusion
Change from baseline geriatric characteristics at 3 months
Karnofsky'score
Time frame: 3 months after inclusion
Change from baseline geriatric characteristics at 3 months
Score MNA
Time frame: 3 months after inclusion
Plan to share: Undecided
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →